Publication: Incidence and outcomes of sepsis-related cardiomyopathy: A prospective cohort study
Issued Date
2021-03-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-85103062330
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.104, No.3 (2021), 497-505
Suggested Citation
Watcharin Chayakul, Surat Tongyoo, Chairat Permpikul Incidence and outcomes of sepsis-related cardiomyopathy: A prospective cohort study. Journal of the Medical Association of Thailand. Vol.104, No.3 (2021), 497-505. doi:10.35755/jmedassocthai.2021.03.12305 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78374
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Incidence and outcomes of sepsis-related cardiomyopathy: A prospective cohort study
Author(s)
Other Contributor(s)
Abstract
Objective: To determine the incidence, predictive factors, and prognosis of sepsis-related cardiomyopathy. Materials and Methods: The present study was a prospective cohort study that enrolled adult septic shock patients admitted to the ICU of Siriraj Hospital (Bangkok, Thailand) between October 2013 and November 2014. All the patients were treated following the surviving sepsis campaign international guidelines 2012. Transthoracic echocardiography was performed during day 1, and then again during days 3 to 4 after septic shock diagnosis. Sepsis-related cardiopathy was diagnosed in patients who had left ventricular ejection fraction (LVEF) at less than 50%. The primary outcome was hospital mortality. The present study was registered in the Thai Clinical Trials Registry (TCTR20200818004). Results: Of the 75 patients enrolled, 24 (32%) were diagnosed as having sepsis-related cardiomyopathy, and 51 sepsis with preserved LVEF. Six of the 51 patients (11.8%) in the sepsis with preserved LVEF group, and nine of the 24 patients (37.5%) in the sepsis-related cardiomyopathy group died in the hospital (p=0.009). Multivariate analysis identified a maximum vasopressor dosage greater than 0.08 mcg/kg/minute and requiring renal replacement therapy as predictive factors associated with sepsis-related cardiomyopathy, while cirrhosis was identified as a protective factor. Sepsis-related cardiomyopathy, pneumonia, and requiring vasopressor were predictive factors associated with hospital mortality, while achieving tissue perfusion goals within six hours after resuscitation was a protective factor against in-hospital death. Conclusion: Sepsis-related cardiomyopathy was identified as a significant type of organ dysfunction among the present study sepsis or septic shock patients, and the mortality rate was high.